HK Stock Movement | GENSCRIPT BIO (01548) Drops Over 4% as Associate Legend Biotech Reports Narrowed Q3 Net Loss of $39.7M
Stock News
Yesterday
GENSCRIPT BIO (01548) fell more than 4% against the market trend, dropping 4.25% to HKD 16.43 by the time of writing, with a turnover of HKD 221 million.
On the news front, on the evening of November 12, Legend Biotech, an associate company of GENSCRIPT BIO, disclosed its financial results for the third quarter ended September 30, 2025. The financial data showed a net loss of $39.7 million for the three months ended September 30, 2025, compared to a net loss of $125.3 million in the same period last year. The adjusted net loss stood at $18.8 million, narrowing from an adjusted net loss of $42 million in the prior-year period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.